ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Jun 9, 2023 CURRENT REPORT
EFFECT Jun 8, 2023
S-1/A Jun 8, 2023 AMENDMENT NO. 4 TO FORM S-1
CORRESP Jun 7, 2023
S-1/A Jun 7, 2023 AMENDMENT NO. 3 TO FORM S-1
S-1/A Jun 1, 2023 AMENDMENT NO. 2 TO FORM S-1
CORRESP Jun 1, 2023
PRE 14A May 31, 2023 PRELIMINARY PROXY STATEMENT
8-K May 26, 2023 CURRENT REPORT
424B4 May 22, 2023 PROSPECTUS SUPPLEMENT
424B3 May 22, 2023 PROSPECTUS SUPPLEMENT
10-Q May 15, 2023 QUARTERLY REPORT
UPLOAD May 11, 2023
S-1/A May 10, 2023 AMENDMENT NO. 1 TO FORM S-1
CORRESP May 10, 2023
UPLOAD May 3, 2023
EFFECT May 1, 2023
EFFECT May 1, 2023
POS AM Apr 26, 2023 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1
POS AM Apr 26, 2023 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1
S-1 Apr 24, 2023 REGISTRATION STATEMENT
8-K Apr 24, 2023 CURRENT REPORT
DEF 14A Apr 14, 2023 DEFINITIVE PROXY STATEMENT
PRE 14A Apr 4, 2023 PRELIMINARY PROXY STATEMENT
8-K/A Apr 3, 2023 AMENDMENT TO FORM 8-K
← Newer Page 8 of 32 · 793 filings Older →